JP2024526237A5 - - Google Patents
Info
- Publication number
- JP2024526237A5 JP2024526237A5 JP2023580418A JP2023580418A JP2024526237A5 JP 2024526237 A5 JP2024526237 A5 JP 2024526237A5 JP 2023580418 A JP2023580418 A JP 2023580418A JP 2023580418 A JP2023580418 A JP 2023580418A JP 2024526237 A5 JP2024526237 A5 JP 2024526237A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- derived
- cell
- population
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163218204P | 2021-07-02 | 2021-07-02 | |
| US63/218,204 | 2021-07-02 | ||
| US202163265190P | 2021-12-09 | 2021-12-09 | |
| US63/265,190 | 2021-12-09 | ||
| US202263341943P | 2022-05-13 | 2022-05-13 | |
| US63/341,943 | 2022-05-13 | ||
| PCT/US2022/073396 WO2023279112A1 (en) | 2021-07-02 | 2022-07-01 | Protected effector cells and use thereof for allogeneic adoptive cell therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526237A JP2024526237A (ja) | 2024-07-17 |
| JP2024526237A5 true JP2024526237A5 (cg-RX-API-DMAC7.html) | 2025-07-09 |
Family
ID=84690870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580418A Pending JP2024526237A (ja) | 2021-07-02 | 2022-07-01 | 同種異系養子細胞療法のための保護されたエフェクター細胞及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240307540A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4363557A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024526237A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240031361A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022304599A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223323A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309797A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015376A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023279112A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024315647A1 (en) * | 2023-08-02 | 2026-02-12 | Fate Therapeutics, Inc. | Solid tumor targeting backbone promoting effector cell differentiation and function |
| WO2025055927A1 (en) * | 2023-09-13 | 2025-03-20 | Qihan Hong Kong Limited | Immunotherapies using hypoimmunogenic engineered cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10829735B2 (en) * | 2015-07-21 | 2020-11-10 | The Trustees Of The University Of Pennsylvania | Methods for improving the efficacy and expansion of immune cells |
| US12036241B2 (en) * | 2017-07-19 | 2024-07-16 | Fate Therapeutics, Inc. | Compositions and methods for immune cell modulation in adoptive immunotherapies |
| BR112020011017A2 (pt) * | 2017-12-22 | 2020-11-17 | Fate Therapeutics, Inc. | células efetoras imunes intensificadas e uso das mesmas |
| AU2019243315A1 (en) * | 2018-03-29 | 2020-09-24 | Fate Therapeutics, Inc. | Engineered immune effector cells and use thereof |
| JP2022510207A (ja) * | 2018-12-02 | 2022-01-26 | フェイト セラピューティクス,インコーポレイテッド | 増強されたiPSC派生エフェクター細胞を使用した免疫療法 |
| AU2020307667A1 (en) * | 2019-06-27 | 2022-01-20 | Crispr Therapeutics Ag | Use of chimeric antigen receptor T cells and NK cell inhibitors for treating cancer |
| KR20220035190A (ko) * | 2019-07-17 | 2022-03-21 | 페이트 세러퓨틱스, 인코포레이티드 | 면역 효과기 세포 조작 및 이의 용도 |
| US20220378831A1 (en) * | 2019-09-25 | 2022-12-01 | Fate Therapeutics, Inc. | Multi-targeting effector cells and use thereof |
| JP7879804B2 (ja) * | 2019-12-06 | 2026-06-24 | フェイト セラピューティクス,インコーポレイテッド | 小化合物を使用するiPSC由来エフェクター免疫細胞の増強 |
-
2022
- 2022-07-01 US US18/575,734 patent/US20240307540A1/en active Pending
- 2022-07-01 EP EP22834452.9A patent/EP4363557A4/en active Pending
- 2022-07-01 WO PCT/US2022/073396 patent/WO2023279112A1/en not_active Ceased
- 2022-07-01 CA CA3223323A patent/CA3223323A1/en active Pending
- 2022-07-01 IL IL309797A patent/IL309797A/en unknown
- 2022-07-01 KR KR1020247004057A patent/KR20240031361A/ko active Pending
- 2022-07-01 AU AU2022304599A patent/AU2022304599A1/en active Pending
- 2022-07-01 MX MX2023015376A patent/MX2023015376A/es unknown
- 2022-07-01 JP JP2023580418A patent/JP2024526237A/ja active Pending